P Moreau, N Robillard, H Avet-Loiseau, D Pineau, N Morineau, N Milpied, JL Harousseau, R Bataille. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma. Haematologica 2004;89(5):547-551; https://doi.org/10.3324/%x.